Advertisement
Advertisement
ASRT
Assertio Holdings, Inc. Common Stock
18.34
USDSponsored
-1.05
-5.42%
Mar 30, 15:59 UTC -4
Closed
After-Market
18.17
-0.17
-0.95%
ASRT Earnings Reports
Positive Surprise Ratio
ASRT beat 22 of 41 last estimates.
54%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$12.19M
/-$1.98
Implied change from Q4 25 (Revenue/ EPS)
-9.96%
/+6.45%
Implied change from Q1 25 (Revenue/ EPS)
-53.97%
/+230.00%
Assertio Holdings, Inc. Common Stock earnings per share and revenue
On Mar 16, 2026, ASRT reported earnings of -1.86 USD per share (EPS) for Q4 25, beating the estimate of -2.76 USD, resulting in a 32.71% surprise. Revenue reached 13.54 million, compared to an expected 16.96 million, with a -20.15% difference. The market reacted with a -1.12% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -1.98 USD, with revenue projected to reach 12.19 million USD, implying an increase of 6.45% EPS, and decrease of -9.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Vivani Medical, Inc. Common Stock (DE)
Report Date
Mar 26, 2026 For Q4 25
Estimate
-Actual
-$0.09
Surprise
-
NRX Pharmaceuticals, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.01
Surprise
-361.54%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
electroCore, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.41
Actual
-$0.34
Surprise
+18.15%
FAQ
What were Assertio Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Assertio Holdings, Inc. Common Stock reported EPS of -$1.86, beating estimates by 32.71%, and revenue of $13.54M, -20.15% below expectations.
How did the market react to Assertio Holdings, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -1.12%, changed from $11.63 before the earnings release to $11.50 the day after.
When is Assertio Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Assertio Holdings, Inc. Common Stock's next earnings report?
Based on 4
analysts, Assertio Holdings, Inc. Common Stock is expected to report EPS of -$1.98 and revenue of $12.19M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement